The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer

Speaking of SurgOnc - A podcast by Annals of Surgical Oncology and Society of Surgical Oncology

Rick Green, MD and Dr. Anna Weiss, MD discuss clinical trials that have defined the role of neoadjuvant endocrine therapy in patients with estrogen receptor-positive breast cancer. Dr. Weiss is author of “The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.” Dr. Weiss is Assistant Professor of Surgery at Harvard Medical School, Boston, MA.